Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Fennec Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 12.00. The median estimate represents a 175.42% increase from the last price of 4.72.
High | 217.8% | 15.00 |
Med | 175.4% | 13.00 |
Low | 154.2% | 12.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | -23.93% |
Average growth rate | -1.98% |
More ▼
Revenue history & estimates in USD
Average growth rate | +35.69% |
Average growth rate | +592.25% |
More ▼